Moderate to Severe Chronic Plaque Psoriasis
1 competing product in clinical development for Moderate to Severe Chronic Plaque Psoriasis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CT-P17 + EU-approved Humira | Celltrion | Phase 3 | Completed | 77 |